4cni
From Proteopedia
(Difference between revisions)
m (Protected "4cni" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4cni is ON HOLD | + | The entry 4cni is ON HOLD until Paper Publication |
Authors: Shaw, S., Bourne, T., Meier, C., Carrington, B., Gelinas, R., Henry, A., Popplewell, A., Adams, R., Baker, T., Rapecki, S., Marshall, D., Neale, H., Lawson, A. | Authors: Shaw, S., Bourne, T., Meier, C., Carrington, B., Gelinas, R., Henry, A., Popplewell, A., Adams, R., Baker, T., Rapecki, S., Marshall, D., Neale, H., Lawson, A. | ||
Description: Crystal structure of the Fab portion of Olokizumab in complex with IL-6 | Description: Crystal structure of the Fab portion of Olokizumab in complex with IL-6 | ||
Revision as of 09:48, 5 February 2014
Unreleased structure
The entry 4cni is ON HOLD until Paper Publication
Authors: Shaw, S., Bourne, T., Meier, C., Carrington, B., Gelinas, R., Henry, A., Popplewell, A., Adams, R., Baker, T., Rapecki, S., Marshall, D., Neale, H., Lawson, A.
Description: Crystal structure of the Fab portion of Olokizumab in complex with IL-6
